09628389559
ASEAN International Oncology Integrative Medicine Session
The 4th ASEAN International Oncology Integrative Medicine Session will be grandly convened in Guangzhou on July 19, 2025, gathering leading oncology specialists from China, Malaysia, Thailand, Indonesia, and across ASEAN nations.
To secure vital opportunities for cancer patients, our hospital launches: "Priority Access Channel".
To secure vital opportunities for cancer patients, our hospital launches: "Priority Access Channel".
Secure Your Golden Consultation Slots with ASEAN Oncology Experts!
Limited Booking time:
June 16 - July 18
June 16 - July 18
Exclusive Benefits
- First 10 appointments:
Exclusive health gifts - Post-consultation treatment at our hospital:
May qualify for financial assistance upon assessment
To obtain your golden consultation slots with ASEAN oncology experts, submit the form to book the consultation.
Cases of Lymphoma Patients in Our Hospital
Lymphoma, as a relatively common hematologic malignancy, requires precise diagnosis and carefully planned treatment strategies for optimal patient outcomes. Many lymphoma patients choose to undergo minimally invasive comprehensive treatment at our hospital. Our specialized Multidisciplinary Team develops tailored comprehensive treatment plans based on each patient’s specific subtype, disease stage, and overall health condition.Below, several patients share their stories of treatment at our hospital.
Hazel (Philippines): Non-Hodgkin Lymphoma
Filipino patient Hazel was diagnosed with stage III non-Hodgkin lymphoma after sudden dysphagia. A 4.3×3.9cm oropharyngeal tumor blocked 80% of her airway, causing complete loss of speech. Drawing on her family’s experience of successful cancer treatment at the same hospital nine years earlier, her relatives decisively chose Guangzhou Modern Cancer Hospital in November 2024.
The hospital implemented comprehensive minimally invasive therapy: interventional perfusion + targeted treatment. After the first session, she regained breathing and speech abilities. Following four treatments, PET-CT scans showed the tumor shrank to 1.7×1.8cm with significant improvement in metastatic lesions.
The hospital implemented comprehensive minimally invasive therapy: interventional perfusion + targeted treatment. After the first session, she regained breathing and speech abilities. Following four treatments, PET-CT scans showed the tumor shrank to 1.7×1.8cm with significant improvement in metastatic lesions.
Gracia (Philippines): Hodgkin Lymphoma
Gracia, an 18-year-old Filipino student, was diagnosed with Hodgkin’s lymphoma in 2023 after a neck tumor (71×43×93mm) forced him to halt his studies. Fearing long-term side effects of chemotherapy, his family sought alternatives and chose Guangzhou Modern Cancer Hospital. The MDT team performed minimally invasive interventional therapy. After just two sessions, the tumor shrank significantly with no discomfort. Now it has returned to normal campus life.
Yoo Khee Chai (Malaysia): Non-Hodgkin Lymphoma
Malaysian patient Yoo Khee Chai was diagnosed with stage IV Non-Hodgkin Lymphoma. Fearing the side effects of traditional chemotherapy, he initially tried alternative therapies (vegetarian diet, supplements, vitamin C injections), but the tumor grew uncontrollably, causing severe facial swelling ("balloon face"), weight loss, and hearing loss.
In February 2025, he sought treatment at Guangzhou Modern Cancer Hospital. The MDT team designed a comprehensive minimally invasive plan: Interventional Therapy + Naturopathy. Remarkably, after just two interventional treatments, the tumor significantly reduced and his hearing improved. Within one month, his facial appearance was largely restored to normal.
In February 2025, he sought treatment at Guangzhou Modern Cancer Hospital. The MDT team designed a comprehensive minimally invasive plan: Interventional Therapy + Naturopathy. Remarkably, after just two interventional treatments, the tumor significantly reduced and his hearing improved. Within one month, his facial appearance was largely restored to normal.
Lymphoma Classification and Stage
1.Lymphoma Classification
Hodgkin Lymphoma (HL)
Accounts for approximately 10% of cases. More common in young adults and the elderly. Generally has a favorable prognosis.
Non-Hodgkin Lymphoma (NHL)
Accounts for approximately 90% of cases. Divided into three categories:
(1)Indolent Lymphoma: Slow progression; patients may survive long-term with the disease.
(2)Aggressive Lymphoma: Requires immediate treatment.
(3)Highly Aggressive Lymphoma: Rare; progresses extremely rapidly.
2.Lymphoma Staging and Five-Year Survival Rates
Staging according to the international Ann Arbor Staging System classifies the extent of lymphoma spread into stages I-IV (including designation for B symptoms).
|
Stage |
Hodgkin Lymphoma |
Non-Hodgkin Lymphoma (e.g., Diffuse Large B-Cell Lymphoma) |
|
Stage I
(Early Stage)
|
>95% Single lymph node group or single organ |
70-85% Localized to a single region |
|
Stage II
(Locally Advanced)
|
90-95% Multiple lymph node groups on the same side of the diaphragm |
60-75% ≥ 2 lymph node groups on the same side of the diaphragm |
|
Stage III
(Advanced)
|
80-85% Involvement on both sides of the diaphragm |
50-65% Widespread lymph node involvement |
|
Stage IV
(Symptomatic
metastatic)
|
75-80% Bone marrow/liver/lung metastasis |
40-55% Multiorgan involvement |
|
Stage III
(Advanced)
|
80-85% Involvement on both sides of the diaphragm |
50-65% Widespread lymph node involvement |
|
Presence of B
Symptoms
(Fever / Night Sweats
/ Weight Loss)
|
Survival ↓5-10% |
Survival ↓10-15% |
Comprehensive Minimally Invasive Treatment of Lymphoma
Lymphoma patients who demonstrate poor response to conventional treatments, are inoperable, or experience recurrence and metastasis may prioritize minimally invasive treatment as an option.
- Interventioanl Therapy
- Local precise drug infusion delivers a drug concentration 2-92 times higher than systemic chemotherapy, resulting in less trauma and fewer side effects.
- Microwave ablation
- Microwave ablation boasts high thermal efficiency and can eradicate lung tumors less than 5 cm in diameter in a single session.
- Radiofrequency Ablation
- Radiofrequency energy is delivered through multi-tined needles into tumor tissue, generating localized high temperatures that induce coagulative necrosis of the tumor cells.
Compared to traditional surgery, radiotherapy, and chemotherapy, minimally invasive treatment offers the following advantages:
- Less Trauma
- Tiny incisions (a few millimeters) reduce tissue damage.
Less bleeding, reducing transfusion needs.
- Faster Recovery
- Shorter hospital stays and quicker return to daily activities.
Lower risk of postoperative complications.
- Less Pain
- Reduced need for painkillers
